Literature DB >> 21573891

Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population.

Tsuyoshi Tanabe1,2, Natsu Yamaguchi3,4, Koichi Matsuda5, Keiko Yamazaki6, Satoshi Takahashi7, Arinobu Tojo7, Makoto Onizuka8, Yoshinobu Eishi9, Hideki Akiyama10, Jun Ishikawa11, Takehiko Mori12, Masamichi Hara13, Kazutoshi Koike14, Keisei Kawa15, Takakazu Kawase16, Yasuo Morishima17, Hiroki Amano3, Mikiko Kobayashi-Miura3, Takeyasu Kakamu18, Yusuke Nakamura5, Shigetaka Asano19, Yasuyuki Fujita3.   

Abstract

Members of the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) family participate in the innate immune system, exerting widespread effects on cytokine secretion, autophagy, and apoptosis. Recent studies in Caucasians revealed the association between mutants of NOD2, a member of the NLR family, and severity of acute graft-versus-host disease (GVHD). NOD2 polymorphism screening has been recommended for donor selection and risk assessment at bone marrow transplantation. To investigate whether NOD2 plays a role in the pathogenesis of GVHD in a Japanese population, we examined DNA from 142 bone marrow transplant patient/donor pairs to detect genetic variation in the NOD2 gene. No genetic variants of NOD2 were associated with the severity of acute GVHD in our patients. However, a weak association between a single nucleotide polymorphism in the NOD2 gene (R471C) and acute myeloid leukemia in the bone marrow patients (p = 0.029, odds ratio 4.08, 95% CI 1.22-13.67) was detected. This polymorphism was not prevalent in 479 Crohn's disease (CD) patients in Japan. These results suggest that, in the Japanese population, unlike the Caucasian, NOD2 is not a major contributor to susceptibility to severe acute GVHD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21573891     DOI: 10.1007/s12185-011-0860-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  34 in total

1.  Impact of highly conserved HLA haplotype on acute graft-versus-host disease.

Authors:  Satoko Morishima; Seishi Ogawa; Aiko Matsubara; Takakazu Kawase; Yasuhito Nannya; Koichi Kashiwase; Masahiro Satake; Hiroo Saji; Hidetoshi Inoko; Shunichi Kato; Yoshihisa Kodera; Takehiko Sasazuki; Yasuo Morishima
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

2.  Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes.

Authors:  Tsuyoshi Tanabe; Ikuo Ishige; Yoshimi Suzuki; Yukie Aita; Asuka Furukawa; Yuki Ishige; Keisuke Uchida; Takashige Suzuki; Tamiko Takemura; Soichiro Ikushima; Masaru Oritsu; Tetsuji Yokoyama; Yukari Fujimoto; Koichi Fukase; Naohiro Inohara; Gabriel Nunez; Yoshinobu Eishi
Journal:  Biochim Biophys Acta       Date:  2006-07-25

3.  Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination.

Authors:  Ernst Holler; Gerhard Rogler; Julia Brenmoehl; Joachim Hahn; Hans Herfarth; Hildegard Greinix; Anne M Dickinson; Gerard Socié; Daniel Wolff; Gottfried Fischer; Graham Jackson; Vanderson Rocha; Beate Steiner; Guenther Eissner; Jeorg Marienhagen; Juergen Schoelmerich; Reinhard Andreesen
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

4.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

5.  Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Authors:  Nagamu Inoue; Kazuo Tamura; Yoshitaka Kinouchi; Yoshihiro Fukuda; Seiichi Takahashi; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez; Yusuke Kishi; Yuji Koike; Tooru Shimosegawa; Takashi Shimoyama; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

6.  Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.

Authors:  T Sasazuki; T Juji; Y Morishima; N Kinukawa; H Kashiwabara; H Inoko; T Yoshida; A Kimura; T Akaza; N Kamikawaji; Y Kodera; F Takaku
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

7.  Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children.

Authors:  Bernd Gruhn; Juliane Intek; Nadine Pfaffendorf; Roland Zell; Selim Corbacioglu; Felix Zintl; James F Beck; Klaus-Michael Debatin; Daniel Steinbach
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-01       Impact factor: 5.742

8.  Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients.

Authors:  Keiko Yamazaki; Yoshihiro Onouchi; Masakazu Takazoe; Michiaki Kubo; Yusuke Nakamura; Akira Hata
Journal:  J Hum Genet       Date:  2007-05-30       Impact factor: 3.172

9.  CARD15/NOD2 mutational analysis in Japanese patients with Crohn's disease.

Authors:  M Sugimura; Y Kinouchi; S Takahashi; H Aihara; S Takagi; K Negoro; N Obana; Y Kojima; K Matsumoto; T Kikuchi; M Hiroki; S Oomori; T Shimosegawa
Journal:  Clin Genet       Date:  2003-02       Impact factor: 4.438

10.  Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9.

Authors:  A H Elmaagacli; M Koldehoff; D W Beelen
Journal:  Bone Marrow Transplant       Date:  2009-03-02       Impact factor: 5.483

View more
  9 in total

1.  Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients.

Authors:  Kumi Ishida; Takuya Inoue; Kaori Fujiwara; Taisuke Sakanaka; Ken Narabayashi; Sadaharu Nouda; Toshihiko Okada; Kazuki Kakimoto; Takanori Kuramoto; Ken Kawakami; Yosuke Abe; Toshihisa Takeuchi; Mitsuyuki Murano; Satoshi Tokioka; Eiji Umegaki; Kazuhide Higuchi
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 2.  Pathogenesis of graft-versus-host disease: innate immunity amplifying acute alloimmune responses.

Authors:  Yoshinobu Maeda
Journal:  Int J Hematol       Date:  2013-08-28       Impact factor: 2.490

3.  Autophagy gene Atg16L1 prevents lethal T cell alloreactivity mediated by dendritic cells.

Authors:  Vanessa M Hubbard-Lucey; Yusuke Shono; Katie Maurer; Mallory L West; Natalie V Singer; Carly G K Ziegler; Cecilia Lezcano; Ana Carolina Fragoso Motta; Karin Schmid; Samuel M Levi; George F Murphy; Chen Liu; Jeffrey D Winkler; Ravi K Amaravadi; Gerhard Rogler; Anne M Dickinson; Ernst Holler; Marcel R M van den Brink; Ken Cadwell
Journal:  Immunity       Date:  2014-10-09       Impact factor: 31.745

Review 4.  Role of non-HLA gene polymorphisms in graft-versus-host disease.

Authors:  Akiyoshi Takami
Journal:  Int J Hematol       Date:  2013-08-15       Impact factor: 2.490

5.  The different roles of innate immune receptors in inflammation and carcinogenesis between races.

Authors:  Natsu Yamaguchi; Yoshimi Suzuki; M H Mahbub; Hidekazu Takahashi; Ryosuke Hase; Yasutaka Ishimaru; Hiroshi Sunagawa; Rie Watanabe; Yoshinobu Eishi; Tsuyoshi Tanabe
Journal:  Environ Health Prev Med       Date:  2017-10-11       Impact factor: 3.674

6.  Phenotyping of Nod1/2 double deficient mice and characterization of Nod1/2 in systemic inflammation and associated renal disease.

Authors:  Ingrid Stroo; Loes M Butter; Nike Claessen; Gwen J Teske; Stephen J Rubino; Stephen E Girardin; Sandrine Florquin; Jaklien C Leemans
Journal:  Biol Open       Date:  2012-10-11       Impact factor: 2.422

7.  Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators.

Authors:  Rhiannon Parkhouse; Joseph P Boyle; Tom P Monie
Journal:  FEBS Lett       Date:  2014-08-02       Impact factor: 4.124

Review 8.  Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives.

Authors:  Tomomi Toubai; Nathan D Mathewson; John Magenau; Pavan Reddy
Journal:  Front Immunol       Date:  2016-11-29       Impact factor: 7.561

9.  Associations of interactions between NLRP3 SNPs and HLA mismatch with acute and extensive chronic graft-versus-host diseases.

Authors:  Hidekazu Takahashi; Naoko Okayama; Natsu Yamaguchi; Yuta Miyahara; Yasuo Morishima; Yutaka Suehiro; Takahiro Yamasaki; Koji Tamada; Satoshi Takahashi; Arinobu Tojo; Shigetaka Asano; Tsuyoshi Tanabe
Journal:  Sci Rep       Date:  2017-10-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.